6505--Omeprazole Dr Capsules- NAC Repack
ID: 36E79725R0002Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/635c2a9dd4a0463c8a12c3bdb3217df1/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Omeprazole DR capsules, structured into two distinct groups: Group 1 for various package sizes of 20mg and 40mg capsules, and Group 2 for bulk quantities of these capsules. The procurement aims to establish reliable supply sources for pharmaceuticals through the VA Pharmaceutical Prime Vendor Program and the Pharmaceutical Repackaging Program, ensuring consistent availability and compliance with regulatory standards. Interested offerors must submit pricing for both groups, adhering to specific packaging and labeling requirements, with the deadline for submissions extended to December 27, 2024, at 2:30 PM CST. For further inquiries, potential bidders can contact Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov.

    Point(s) of Contact
    Teresa HussainContract Specialist
    (708) 786-5852
    teresa.hussain@va.gov
    Files
    Title
    Posted
    36E79725R0002_1.docx
    The Department of Veterans Affairs (VA) National Acquisition Center plans to issue Request for Proposal (RFP) 36E79725R0002 for the procurement of Omeprazole DR Capsules. This unrestricted procurement is intended for various health service agencies, including VA and the Bureau of Prisons, among others. The contract will likely be awarded to one responsible offeror per group, with a contract duration of one year plus four optional one-year extensions. Offerors must specify the exact name and unique NDC number of the drug and ensure that packaging meets specific safety requirements, including a convertible safety cap. The solicitation is set to be electronically issued around November 19, 2024, with an closing date of December 3, 2024. Estimated annual requirements are outlined for two groups: Group 1 for Other Government Agencies and Group 2 for the VA Repack Program, detailing expected quantities of various Omeprazole formulations. This pre-solicitation highlights the VA's commitment to maintaining a reliable supply chain for essential medications while ensuring compliance with safety and labeling standards. Interested parties can obtain further information and updates through SAM.gov.
    36E79725R0002.docx
    The document outlines a solicitation from the Department of Veterans Affairs (VA) for a pharmaceutical contract, specifically focusing on Omni-Pill 20mg and 40mg capsules. The purpose is to establish supply sources for pharmaceuticals through the VA Pharmaceutical Prime Vendor Program and the Pharmaceutical Repackaging Program, ensuring consistent availability and competitive pricing. The solicitation allows for two groups of items: Group 1 (for Other Government Agencies) and Group 2 (specifically for VA). Offerors must submit prices for base and option years across all required line items, noting specific details such as dosage forms and packaging sizes. Each submission must include an 11-digit National Drug Code (NDC) and cannot exceed two decimal places in pricing, inclusive of a 0.5% Cost Recovery Fee for contract administration. The solicitation includes stringent requirements regarding compliance with manufacturing practices, packaging standards, traceability through barcoding, and Drug Supply Chain Security Act mandates. It emphasizes the importance of maintaining Good Manufacturing Practices (cGMP) and outlines consequences for backorders and non-compliance. This solicitation reflects the government's commitment to sourcing pharmaceutical products efficiently while maintaining compliance with regulatory standards.
    36E79725R0002 0001.docx
    The document is an amendment to the solicitation for Omeprazole (36E79725R0002) issued by the Department of Veterans Affairs National Acquisition Center. The key purpose of this amendment is to extend the deadline for bids to December 10, 2024, at 2:30 PM CST. No other modifications to the original solicitation terms are mentioned. The document outlines the procedures that bidders must follow to acknowledge receipt of the amendment and emphasizes that failure to acknowledge it could lead to rejection of their offer. The amendment is officially signed by the contracting officer, Teresa Hussain, indicating adherence to federal procurement protocols. This extension provides potential contractors with additional time to prepare their offers, reflecting the government's commitment to ensuring a fair and thorough bidding process for federal contracts.
    36E79725R0002 0002.docx
    The document is an amendment for a federal solicitation (36E79725R0002) for Omeprazole, issued by the Department of Veterans Affairs. The primary purpose of this amendment is to adjust the estimated annual quantities of the product and extend the deadline for offer submissions to December 27, 2024, at 2:30 PM CST. No other modifications are made to the original solicitation terms. The amendment process requires bidders to acknowledge receipt of this amendment in one of several specified ways. This document is critical in informing potential contractors about updates to bidding opportunities and ensuring compliance with Federal Acquisition Regulation (FAR) requirements. Overall, it underscores the VA's commitment to maintaining communication and clarity throughout the procurement process while reflecting ongoing adjustments to purchasing needs.
    Amend 02_page 2_OMP.docx
    This document pertains to a federal solicitation for the procurement of Omeprazole DR capsules, structured into two distinct groups for evaluation: Group 1 (various package sizes of 20mg and 40mg capsules) and Group 2 (bulk capsules). The Contracting Officer will complete specific non-negotiable fields regarding contract awards, effective dates, and ordering periods. Offerors must submit pricing for both groups, either collectively or separately, and all submitted prices must adhere to specified formatting criteria. For Group 1, proposals must include unit-of-use packaging details and requirements, such as safety caps and label dimensions, with quantities specified for each option year. Group 2 requires bulk quantities of both 20mg and 40mg capsules, emphasizing the minimum and preferred package sizes as well as pricing related to packaging costs. The government will evaluate offers based on the lowest aggregate price for Group 1 (per bottle) and Group 2 (per capsule), along with any added repackaging costs for smaller tablet counts. The estimates are guiding but not guaranteed purchases, and bulk products must have substantial shelf lives. This comprehensive framework ensures competitive bidding processes and aligns with federal standards in pharmaceutical procurement.
    Lifecycle
    Title
    Type
    6505--Omeprazole Dr Capsules- NAC Repack
    Solicitation
    6505--Omeprazole Dr Capsules- NAC Repack
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the procurement of Verapamil Hydrochloride (HCL) Tablets, aimed at establishing a contract for the supply of this pharmaceutical product through the VA and Department of Defense Pharmaceutical Prime Vendor Programs. The solicitation requires bidders to provide pricing for the base year and four option years, ensuring compliance with current Good Manufacturing Practices (cGMP) and adherence to FDA regulations, including drug registration and barcoding requirements. This procurement is crucial for maintaining the supply of essential medications for VA healthcare needs. Interested parties must submit their offers by December 24, 2024, at 2:30 PM CST, and can direct inquiries to Contract Specialist Nicholas I. McGregor at Nicholas.McGregor@va.gov.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0095 770-25-1-801-0132 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement for Ferrous Sulfate 324 mg EC Tablets, with a total quantity of 24,000 tablets to be delivered to multiple CMOP locations. The procurement requires compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that all products be bar-coded according to industry standards, ensuring safety and traceability. This solicitation underscores the VA's commitment to providing quality pharmaceutical supplies for its healthcare services, with a submission deadline for quotes set for December 30, 2024, at 9:00 AM CST. Interested vendors must submit their proposals, including a signed SF1449, an Excel price schedule, and a state wholesale distributor license, to the primary contact, Michael W McAlhaney, at Michael.McAlhaney@va.gov.
    6505--765_Pharmaceuticals_VA CMOP Hines_36C77025Q0088 765-25-1-021-0194 -Hines CMOP 4 PHARMACEUTICALS -(VA-25-00028394)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply various pharmaceuticals for delivery to the Consolidated Mail Outpatient Pharmacy (CMOP) in Hines, Illinois, under solicitation number 36C77025Q0088. The procurement includes specific items such as PEG-400 solution, Sevelamer carbonate tablets, Fenofibrate capsules, and Febuxostat tablets, with a total quantity specified for each item. These pharmaceuticals are essential for ensuring the health and well-being of veterans, highlighting the importance of a reliable supply chain in the healthcare sector. Interested vendors must submit their quotes, including a signed SF 1449 cover page and compliance documentation, by December 27, 2024, at 9:00 AM CST, with the estimated award date set for December 31, 2024. For further inquiries, vendors can contact Jeffrey A. Blackard at jeffrey.blackard@va.gov or by phone at (913) 684-0142.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0060 762-25-1-040-0111 -Tucson CMOP MIRTAZAPINE -(VA-25-00015396)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Mirtazapine 7.5mg tablets for delivery to the Tucson CMOP facility under solicitation number 36C77025Q0060. The procurement requires a total quantity of 5,280 tablets and emphasizes compliance with the Drug Supply Chain Security Act (DSCSA), as well as adherence to the Buy American statute, necessitating separate quotes for foreign and domestic products. This acquisition is crucial for ensuring a reliable supply of pharmaceuticals to support the health programs of veterans, with a response deadline set for December 27, 2024, and an estimated award date of December 31, 2024. Interested vendors must submit their quotes, including a signed SF1449 form, a completed price schedule in Excel format, and proof of state wholesale distributor licensure, to Jeffrey Blackard at jeffrey.blackard@va.gov.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.